Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls - Summary of an AASLD Hepatitis Single Topic Conference, Chicago, IL, February 27-March 1, 2003

被引:48
作者
Pawlotsky, JM
McHutchison, JG [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Ctr Clin, Durham, NC 27705 USA
[2] Univ Paris 12, Henri Mondor Hosp, Dept Virol EA 3489, Creteil, France
关键词
D O I
10.1002/hep.20065
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:554 / 567
页数:14
相关论文
共 110 条
[1]   Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[2]   Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Ago, H ;
Adachi, T ;
Yoshida, A ;
Yamamoto, M ;
Habuka, N ;
Yatsunami, K ;
Miyano, M .
STRUCTURE, 1999, 7 (11) :1417-1426
[3]   Cell-free replication of the hepatitis C virus subgenomic replicon [J].
Ali, N ;
Tardif, KD ;
Siddiqui, A .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12001-12007
[4]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[5]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[6]   Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection [J].
Bassett, SE ;
Guerra, B ;
Brasky, K ;
Miskovsky, E ;
Houghton, M ;
Klimpel, GR ;
Lanford, RE .
HEPATOLOGY, 2001, 33 (06) :1479-1487
[7]   Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C [J].
Baumert, TF ;
Wellnitz, S ;
Aono, S ;
Satoi, J ;
Herion, D ;
Gerlach, JT ;
Pape, GR ;
Lau, JYN ;
Hoofnagle, JH ;
Blum, HE ;
Liang, TJ .
HEPATOLOGY, 2000, 32 (03) :610-617
[8]   Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy [J].
Bekkering, FC ;
Brouwer, JT ;
Leroux-Roels, G ;
Van Vlierberghe, H ;
Elewaut, A ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 1998, 28 (06) :960-964
[9]   Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin [J].
Bekkering, FC ;
Brouwer, JT ;
Hansen, BE ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 2001, 34 (03) :435-440
[10]   Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model [J].
Bekkering, FC ;
Stalgis, C ;
McHutchison, JG ;
Brouwer, JT ;
Perelson, AS .
HEPATOLOGY, 2001, 33 (02) :419-423